pipette
ENEnglish

Protection against disseminated disease following reinfection with Mycobacterium tuberculosis requires CD8+ lymphocytes

A. W. Simonson, M. C. Chao, E. G. Bothwell, F. Shan, M. A. Rodgers, L. E. Hood, F. Hopkins, M. R. Chase, A. Callendrello, A. A. Smith, R. J. Kelly, C. L. Ameel, E. Klein, J. Schober, K. Kracinovsky, J. A. Tomko, H. Chishti, M. Malin, H. J. Borish, P. Maiello, C. A. Scanga, P. L. Lin, A. K. Shalek, S. M. Fortune, J. L. Flynn

Preprint

En palabras de los autores

Concomitant immunity is protective adaptive immunity conferred by pre-existing infection against subsequent exposures. This phenomenon is effective in the context of human tuberculosis (TB) and has been successfully recapitulated in non-human primates (NHPs). We previously demonstrated that depletion of CD4 T cells prior to secondary challenge with Mycobacterium tuberculosis (Mtb) only partially abrogated protection, implicating a critical role for additional cell types. Here, we describe the effects of depleting CD8 expressing cells in this model. CD4+ T cells in the airway were unable to compensate for lost cytotoxicity due to CD8 depletion. Contrary to the results of CD4 depletion, CD8 depleted animals exhibited a unique inability to limit Mtb dissemination, with significant lymph node involvement despite a short 4-week infection. These data suggest that concomitant immunity relies on non-redundant roles played by CD8+ lymphocytes. Thus, future vaccines should be designed to induce effective responses by both CD4+ and CD8+ populations to maximize efficacy.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 4 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.29.762796